glp-1 drugs made from Compound versions of for weight loss halted by FDA Retatrutide for weight loss: Study
Description
Dapagliflozin monotherapy in drug-nave patients with diabetes: A randomized-controlled trial of low-dose range
The reason I say this is because with Triumph-1 Eli Lilly only had the raw trial data for a couple weeks, so they scrambled to pull out the stuff thats relevant to a conference such as this meaning any deeper exploration on the liver and kidney were left out
As of December 2025, there is a centralized litigation for people alleging vision loss caused by Wegovy and other GLP-1 drugs
Were any of the results surprising
SURPASS-5 Compared tirzepatide vs placebo in people taking Insulin glargine with or without metformin
Patience helps
